Keith Dewedoff’s Post

Biotech CFO & Corporate Development

2d Edited

Super Stoked! Excited to see this Stealthco getting to its first NDA submission as well as continuing to push its pipeline programs in the Infectious Disease space. Thanks to all of Kaizen's advisors as well as the NDA Partners team for supporting the company throughout the years to get to this point!

Kaizen Biosciences Announces Multiple Abstract Acceptances and Presents Pediatric Antibiotic PK Data to ISOM; Targets FDA’s New CNPV Pathway Ahead of September NDA Filing

Kaizen Biosciences Announces Multiple Abstract Acceptances and Presents Pediatric Antibiotic PK Data to ISOM; Targets FDA’s New CNPV Pathway Ahead of September NDA Filing

businesswire.com

16 Comments

Krystal Haynes, graphic

Global Health Transformation Leader

2d

Congrats Keith! 🎉 major milestone!

Brian Collins, graphic

2d

Congrats Keith and the Kaizen team!

Lynne Frick, graphic

President and Chief Executive Officer at Cell X Technologies

2d

Congrats Keith! 🎉

Julie Giorgi, MBA, graphic

Julie Giorgi, MBA

Global Compliance Leader | Driving Integrity and Operational Excellence

1d

This is great news Keith!! Super proud of you!!

Barb Carlin CPA, MBA, graphic

Barb Carlin CPA, MBA

Managing Director, Mid Atlantic Region at Danforth Advisors

2d

Congrats Keith! 🎉

Gerry O'Connor, graphic

1d

Warmest congratulations Keith!

Dennis Murphy, graphic

Market Access & Commercial Strategy

1d

Congrats, Keith! Great news.

Justin Knepp, graphic

Senior Director, Client Services

23h

Amazing news! Congrats Keith!

Kevin Kovaleski, graphic

Kevin Kovaleski

Innovative Life Sciences Executive | Strategic Visionary | VP Marketing, Sales, Commercial Development | Diverse Therapeutic Area Experience | Rare Disease | Board Member

2d

Congrats to you and the Kaizen team Keith!

See more comments

To view or add a comment, sign in

Keith Dewedoff

1,950 followers

30 Posts

View Profile Follow

Explore topics